Cannabis Wire spoke with Jaci Flug, former general counsel for the New York State Liquor Authority, about her new role at alcohol delivery platform Drizly and its cannabis arm Lantern, and Lantern’s president.
Cannabis Wire caught up with the Canopy Growth founder and former CEO on his decision to join Vireo Health as executive chairman.
Colorado regulator Ashley Kilroy tells Cannabis Wire about how equity was top of mind at the 2019 Marijuana Management Symposium in Denver, and about lessons learned from being first.
Cannabis Wire co-founder interviews Barrington Miller, CSE director of listed client services, at the ArcView Group’s investor forum.
On Sunday, CNN will air Gupta’s fifth documentary about cannabis as medicine. Cannabis Wire caught up with Gupta to learn more about his thoughts on the so-called CBD craze and forthcoming FDA regulations.
Q&A: David Bronner’s New Certification System Aimed at California’s Small Farmers Goes Beyond Organics
As the state works up an almost-organic standard, Brother David’s is backing one that also includes soil health, labor fairness, and community engagement.
Cannabis Wire spoke with PAX’s first general manager for Canada about new markets, shifting consumer preferences, and the opportunities afforded by federal legalization.
“It is our responsibility to bring a legitimate and serious educational response to... an issue that is straining many municipalities, state agencies and police and other public safety officials.”
A recent cannabis and opioid study highlighted that “corporate actors” with “deep pockets have substantial ability to promote congenial results, as suffering people are desperate for effective solutions.”
MPP’s new executive director talks equity, federal legalization, and the organization’s role in the booming, multibillion dollar global cannabis industry.
A presidential candidate says ending prohibition is the heart of the matter, and that other reforms, like criminal justice, would follow. She hopes for bipartisan support.
Q&A: After a survey shows a hunger for answers among clinicians and patients alike, a foundation gathers experts to chart a research path. Here’s why.
In an exclusive interview, US Attorney Billy Williams weighs in on banking, hemp, overproduction, illicit-market diversion—and cannabis regulators who fail to think things out.
New York Senator Diane Savino, an architect of the state’s medical-cannabis law, has plenty to say about the governor’s ideas for recreational legalization.
The Research Director of UCLA's Cannabis Research Initiative talks opioids, how men and women experience cannabis differently, and Alex Berenson's misrepresentation of cannabis research.
Josh Hovey shares the Michigan Cannabis Industry Association’s plans to work with the Democratic administration tasked with bringing medical and recreational use sales above board.